Abstract: Apparatuses, systems, and methods for controlling cache allocations in a configurable combined private and shared cache in a processor-based system. The processor-based system is configured to receive a cache allocation request to allocate a line in a share cache structure, which may further include a client identification (ID). The cache allocation request and the client ID can be compared to a sub-non-uniform memory access (NUMA) (sub-NUMA) bit mask and a client allocation bit mask to generate a cache allocation vector. The sub-NUMA bit mask may have been programmed to indicate that processing cores associated with a sub-NUMA region are available, whereas processing cores associated with other sub-NUMA regions are not available, and the client allocation bit mask may have been programmed to indicate that processing cores are available.

Abstract: The present invention relates to a method of prognostic of the survival of human subject suffering from chronic myelomonocytic leukemia (CMML) based on the differential expression of six genes in a test sample of PBMC cells obtained from said human subject and in a control sample of normal cells, wherein said expression level indicates if the human subject from which the test sample has been obtained will have long-term or short-term survival.

Abstract: A method for manufacturing a protective layer for protecting skin and tissues in a vicinity of the skin includes the steps of: forming a mixture comprising approximately 15% of dimethyl-vinyl-terminated polydimethylsiloxane with a viscosity greater than 20,000 mPa·s, approximately 25% of dimethyl-vinyl-terminated polydimethylsiloxane with a viscosity between 200 and 20,000 mPa·s, approximately 45% of trimethyl-terminated polydimethylsiloxane, approximately 12% of trimethylsiloxy-treated pyrogenic silica, and approximately 3% of dimethyl-hydrogen-terminated co-polydimethylsiloxane-polymethyl-hydrogen-siloxane; polymerizing at least partially the mixture to obtain a polymer gel; and forming the protective layer using the polymer gel. The polymer gel has, at a temperature of 35° C.

Abstract: A method for manufacturing a protective layer for protecting skin and tissues in a vicinity of the skin includes the steps of: forming a mixture comprising approximately 15% of dimethyl-vinyl-terminated polydimethylsiloxane with a viscosity greater than 20,000 mPa.s, approximately 25% of dimethyl-vinyl-terminated polydimethylsiloxane with a viscosity between 200 and 20,000 mPa.s, approximately 45% of trimethyl-terminated polydimethylsiloxane, approximately 12% of trimethylsiloxy-treated pyrogenic silica, and approximately 3% of dimethyl-hydrogen-terminated co-polydimethylsiloxane-polymethyl-hydrogen-siloxane; polymerizing at least partially the mixture to obtain a polymer gel; and forming the protective layer using the polymer gel. The polymer gel has at 35° C., when a stress frequency varies between 0 and 100 Rd/s, a rigidity or elastic component varying from 11,000 to 20,000 Pa, a viscosity or cushioning component varying from 700 to 8,000 Pa, and a cushioning factor or Tan Delta varying from 0.06 to 0.38.

Abstract: The invention relates to chiral separation chromatographic and electrophoretic techniques. The aim of said invention is to obtain chiral stationary and mobile phases comprising an oligonucleotide which is specifically selected by a SELEX method against an enantiomer to be separated as a special-purpose chiral selector. Methods for separating enantiomers by the chiral stationary and mobile phases are also disclosed.

Abstract: The invention concerns a hygienic agent for use in hemodialysis. This hygienic agent based on peracetic acid has an aqueous solution containing 6 to 8 weight % hydrogen peroxide, 0.1 to 1 weight % peracetic acid and 2 to 10 weight % acetic acid. Application to the disinfection, sterilization of dialysis generators, dialyzers, hemofilters and hemodialyzers and circuits of water treatment for hemodialysis.

Abstract: The invention concerns a hygienic agent for use in hemodialysis. This hygienic agent based on peracetic acid has an aqueous solution containing 6 to 8 weight % hydrogen peroxide, 0.1 to 1 weight % peracetic acid and 2 to 10 weight % acetic acid. Application to the disinfection, sterilization of dialysis generators, dialyzers, hemofilters and hemodialyzers and circuits of water treatment for hemodialysis.

Abstract: Alkaline aqueous liquid bleaching detergents that remain stable during storage contain monohydrated sodium perborate, a Mg 3.5 SiO.sub.2 magnesium silicate, sodium acid pyrophosphate and a viscosity regulator composed of dialkylether polyethyleneglycol copolymers.The detergents can be used for washing and bleaching at temperatures between 40.degree. and 90.degree. C.

Abstract: Commercial solutions of noncorrosive and time-stable carboxylic peracids, particularly peracetic acid, contain an acid of oxidizing nature, such as nitric acid, present in a weight percentage at least equal to that of the carboxylic peracid. Such solutions, diluted with ordinary water, are useful for the sterilization and microbiological disinfection of asceptic enclosures, and of equipment of the food industry, particularly the milk industry, with reduced risk of corrosion to the equipment.